MedTrace Logo

Brief Intervention to Promote Smoking Cessation in DM Smokers

NCT02875782 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 557

Last updated 2016-08-23

No results posted yet for this study

Summary

The study is a randomized controlled trial (RCT) on a tailored smoking cessation intervention targeted type 2 diabetic patients who smoke (DM intervention). The objectives are:

1. to study the effectiveness of the DM intervention in achieving (a) smoking cessation, (b) smoking reduction, and (c) progress to a higher stage of readiness to quit;
2. the changes in levels of HbA1c between (a) the intervention group and the controls, and (b) quitters and continuing smokers;
3. the predictive factors for the success of the outcomes above.

Conditions

  • Smoking

Interventions

BEHAVIORAL

Smoking cessation and DM specific component intervention

A brief stage-matched smoking cessation intervention plus a DM-specific leaflet on smoking cessation

BEHAVIORAL

Control group

A simple, brief advice and a self-help general leaflet on smoking cessation

Sponsors & Collaborators

  • The University of Hong Kong

    lead OTHER

Principal Investigators

  • William Ho Cheung LI, PhD · The University of Hong Kong

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2013-04-30
Completion
2013-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02875782 on ClinicalTrials.gov